A Study of Single-dose ALXN2050 in Healthy Adults
Clinical trial NCT05047458 · COMPLETED
Trial details
- NCT number
- NCT05047458
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2018-04-13
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.